Prosecution Insights
Last updated: April 19, 2026

BIONTECH SE

16 pending office actions

Portfolio Summary

16
Total Pending OAs
6
Final Rejections
10
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18549346 MULTISPECIFIC BINDING AGENTS AGAINST CD40 AND CD137 IN THERAPY AEDER, SEAN E 1642 Non-Final OA Sep 06, 2023
18268594 Treatment Schedule for Cytokine Proteins GOMEZ RODRIGUEZ, JULIO WASHINGTON 1637 Non-Final OA Jun 20, 2023
18258343 Therapeutic RNA for Treating Cancer PUTTLITZ, KARL J 1646 Non-Final OA Jun 20, 2023
18268124 THERAPEUTIC RNA FOR TREATING CANCER LIPPOLIS, ALEXANDRA ROSE 1637 Non-Final OA Jun 16, 2023
18266135 RNA MANUFACTURING ZAHORIK, AMANDA MARY 1636 Non-Final OA Jun 08, 2023
18036681 PHARMACEUTICAL COMPOSITIONS COMPRISING PARTICLES AND MRNA AND METHODS FOR PREPARING AND STORING THE SAME LIPPERT, JOHN WILLIAM 1615 Non-Final OA May 12, 2023
18036676 ENHANCED FORMULATION STABILIZATION AND IMPROVED LYOPHILIZATION PROCESSES MACH, ANDRE 1615 Final Rejection May 12, 2023
18246533 PREPARATION AND STORAGE OF LIPOSOMAL RNA FORMULATIONS SUITABLE FOR THERAPY NGUYEN, NGOC-ANH THI 1615 Final Rejection Mar 24, 2023
18044955 AGENTS AND METHODS FOR TARGETED DELIVERY TO CELLS VAN BUREN, LAUREN K 1638 Non-Final OA Mar 10, 2023
18071705 RNA FORMULATION FOR IMMUNOTHERAPY SHOMER, ISAAC 1612 Final Rejection Nov 30, 2022
17915567 RNA COMPOSITIONS TARGETING CLAUDIN-18.2 LI, RUIXIANG 1674 Non-Final OA Sep 29, 2022
17817033 MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137 KAUFMAN, CLAIRE M 1674 Non-Final OA Aug 03, 2022
17759906 TREATMENT INVOLVING ANTIGEN VACCINATION AND BINDING AGENTS BINDING TO PD-L1 AND CD137 SULLIVAN, DENNIS JOHN 1642 Final Rejection Aug 01, 2022
17627066 METHOD FOR DETERMINING AT LEAST ONE PARAMETER OF A SAMPLE COMPOSITION COMPRISING NUCLEIC ACID, SUCH AS RNA, AND OPTIONALLY PARTICLES SANFORD, DIANA PATRICIA 1687 Final Rejection Jan 13, 2022
17609358 NOVEL GARDNERELLA ENDOLYSINS AND USES THEREOF EDWARDS, JESSICA FAYE 1657 Non-Final OA Nov 05, 2021
16318895 Selecting Neoepitopes as Disease-Specific Targets for Therapy with Enhanced Efficacy GODDARD, LAURA B 1642 Final Rejection Jan 18, 2019

Managing BIONTECH SE's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month